| 11/13/2026 4:30 PM | Alaunos Therapeutics (1107421) Filer | Form PRE 14A | |
| 10/23/2026 3:30 PM | Alaunos Therapeutics (1107421) Filer | Form 8-K Current report pursuant to Section 13 or 15(d) | |
| 10/21/2026 3:30 PM | Alaunos Therapeutics (1107421) Filer | Form 8-K Current report pursuant to Section 13 or 15(d) | |
| 10/15/2026 6:55 PM | Alaunos Therapeutics (1107421) Subject Postma Robert W (1827847) Filed by | Form SCHEDULE 13D/A | |
| 10/15/2026 3:01 PM | Alaunos Therapeutics (1107421) Subject Fairmount Funds Management LLC (1802528) Filed by | Form SCHEDULE 13D | |
| 10/15/2026 3:05 PM | Alaunos Therapeutics (1107421) Issuer Fairmount Funds Management LLC (1802528) Reporting Fairmount Healthcare Co-Invest VII L.P. (2157639) Reporting Fairmount Healthcare Fund II L.P. (1769651) Reporting Harwin Peter Evan (1663607) Reporting Kiselak Tomas (1830177) Reporting | Form 3 Initial statement of beneficial ownership of securities | |
| 10/13/2026 8:28 AM | Alaunos Therapeutics (1107421) Filer | Form 8-K Current report pursuant to Section 13 or 15(d) | |
| 10/09/2026 3:30 PM | Alaunos Therapeutics (1107421) Filer | Form 8-K Current report pursuant to Section 13 or 15(d) | |
| 10/08/2026 3:30 PM | Alaunos Therapeutics (1107421) Issuer Jerman Michael Allen (1979732) Reporting | Form 4 Statement of changes in beneficial ownership of securities | |
| 10/08/2026 3:30 PM | Alaunos Therapeutics (1107421) Issuer Postma Robert W (1827847) Reporting | Form 4 Statement of changes in beneficial ownership of securities | |
| 10/08/2026 3:30 PM | Alaunos Therapeutics (1107421) Issuer Vieser Jaime (1846045) Reporting | Form 4 Statement of changes in beneficial ownership of securities | |
Get the Latest News and Ratings for TCRT and Related Stocks Enter your email address below to receive the latest news and analysts' ratings for Alaunos Therapeutics and its competitors with MarketBeat's FREE daily newsletter.
|
| 10/08/2026 3:30 PM | Alaunos Therapeutics (1107421) Issuer Weis Holger (1846984) Reporting | Form 4 Statement of changes in beneficial ownership of securities | |
| 09/22/2026 3:30 PM | Alaunos Therapeutics (1107421) Filer | Form 8-K Current report pursuant to Section 13 or 15(d) | |
| 09/21/2026 4:00 PM | Alaunos Therapeutics (1107421) Filer | Form 424B3 | |
| 09/16/2026 8:03 PM | Alaunos Therapeutics (1107421) Filer | Form 8-K Current report pursuant to Section 13 or 15(d) | |
| 08/14/2026 3:31 PM | Alaunos Therapeutics (1107421) Filer | Form 10-Q General form for quarterly reports under Section 13 or 15(d) | |
| 07/02/2026 8:24 PM | Alaunos Therapeutics (1107421) Filer | Form S-8 Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans | |
| 07/02/2026 4:33 PM | Alaunos Therapeutics (1107421) Issuer Weis Holger (1846984) Reporting | Form 4 Statement of changes in beneficial ownership of securities | |
| 06/29/2026 7:30 AM | Alaunos Therapeutics (1107421) Filer | Form 8-K Current report pursuant to Section 13 or 15(d) | |
| 06/17/2026 3:47 PM | Alaunos Therapeutics (1107421) Issuer Weis Holger (1846984) Reporting | Form 4 Statement of changes in beneficial ownership of securities | |
| 05/27/2026 3:33 PM | Alaunos Therapeutics (1107421) Issuer Weis Holger (1846984) Reporting | Form 4 Statement of changes in beneficial ownership of securities | |
| 05/26/2026 10:00 AM | Alaunos Therapeutics (1107421) Filer | Form 8-K Current report pursuant to Section 13 or 15(d) | |
| 05/18/2026 7:00 AM | Alaunos Therapeutics (1107421) Filer | Form 8-K Current report pursuant to Section 13 or 15(d) | |
| 05/15/2026 4:29 PM | Alaunos Therapeutics (1107421) Filer | Form 10-Q General form for quarterly reports under Section 13 or 15(d) | |
| 05/01/2026 3:30 PM | Alaunos Therapeutics (1107421) Issuer Vieser Jaime (1846045) Reporting | Form 4 Statement of changes in beneficial ownership of securities | |
| 05/01/2026 3:15 PM | Alaunos Therapeutics (1107421) Issuer Jerman Michael Allen (1979732) Reporting | Form 4 Statement of changes in beneficial ownership of securities | |
| 05/01/2026 3:18 PM | Alaunos Therapeutics (1107421) Issuer Postma Robert W (1827847) Reporting | Form 4 Statement of changes in beneficial ownership of securities | |
| 04/30/2026 4:14 PM | Alaunos Therapeutics (1107421) Filer | Form 10-K/A | |
| 04/15/2026 3:32 PM | Alaunos Therapeutics (1107421) Filer | Form 8-K Current report pursuant to Section 13 or 15(d) | |
| 03/31/2026 3:33 PM | Alaunos Therapeutics (1107421) Filer | Form 10-K Annual report pursuant to Section 13 or 15(d) | |
| 03/05/2026 10:33 AM | Alaunos Therapeutics (1107421) Subject Price Adrian (2094682) Filed by | Form SCHEDULE 13D/A | |
| 03/02/2026 5:29 AM | Alaunos Therapeutics (1107421) Filer | Form 8-K Current report pursuant to Section 13 or 15(d) | |
| 02/24/2026 3:56 PM | Alaunos Therapeutics (1107421) Subject Price Adrian (2094682) Filed by | Form SCHEDULE 13D/A | |
| 01/15/2026 3:15 PM | Alaunos Therapeutics (1107421) Issuer Vieser Jaime (1846045) Reporting | Form 4 Statement of changes in beneficial ownership of securities | |
| 01/15/2026 3:15 PM | Alaunos Therapeutics (1107421) Issuer Postma Robert W (1827847) Reporting | Form 4 Statement of changes in beneficial ownership of securities | |
| 01/15/2026 3:15 PM | Alaunos Therapeutics (1107421) Issuer Jerman Michael Allen (1979732) Reporting | Form 4 Statement of changes in beneficial ownership of securities | |
| 01/08/2026 7:30 AM | Alaunos Therapeutics (1107421) Filer | Form 8-K Current report pursuant to Section 13 or 15(d) | |
| 12/23/2025 4:18 PM | Alaunos Therapeutics (1107421) Filer | Form 8-K Current report pursuant to Section 13 or 15(d) | |
| 12/11/2025 4:17 PM | Alaunos Therapeutics (1107421) Filer | Form 424B8 | |
| 12/05/2025 2:20 PM | Alaunos Therapeutics (1107421) Subject Price Adrian (2094682) Filed by | Form SCHEDULE 13D/A | |
| 11/26/2025 8:32 PM | Alaunos Therapeutics (1107421) Issuer Vieser Jaime (1846045) Reporting | Form 4 Statement of changes in beneficial ownership of securities | |
My public warning after 55 years of watching the markets (Ad) Dr. Martin D. Weiss has publicly predicted six major American market crashes over his 55-year career, each warning issued before the crisis hit.
Now the founder of Weiss Ratings, the only conflict-free rating agency in America, says he is watching a $3 trillion problem that could trigger a chain reaction across markets and banks. See Martin Weiss's full warning before this risk spreads further |
| 11/26/2025 8:26 PM | Alaunos Therapeutics (1107421) Issuer Jerman Michael Allen (1979732) Reporting | Form 4 Statement of changes in beneficial ownership of securities | |
| 11/26/2025 8:26 PM | Alaunos Therapeutics (1107421) Issuer Postma Robert W (1827847) Reporting | Form 4 Statement of changes in beneficial ownership of securities | |